From: Age and fecal microbial strain-specific differences in patients with spondyloarthritis
Characteristic | SpA | Controls |
---|---|---|
n | 11 | 10 |
Age (years), mean ± SD | 52 ± 7.4 | 47 ± 8.1 |
BMI (kg/m2), mean ± SD | 32 ± 7.8 | 28 ± 4.8 |
Disease duration (years), mean ± SD | 11 ± 9.5 | Not applicable |
Male | 4 (36%) | 3 (30%) |
Race | ||
 Caucasian | 9 (82%) | 6 (60%) |
 African-American | 2 (18%) | 4 (40%) |
Diagnosis | Â | Not applicable |
 Undifferentiated SpA | 1 (9.1%) | |
 Ankylosing spondylitis | 6 (54%) | |
 IBD-associated arthritis | 1 (9.1%) | |
 Psoriatic arthritis | 2 (18%) | |
 Reactive arthritis | 1 (9.1%) | |
Current medications | ||
 None | 2 (18%) | 10 (100%) |
 Traditional DMARDs alone | 5 (45%) | |
 TNFi alone | 3 (27%) | |
 DMARDs plus TNFi | 1 (9.1%) | |
HLA-B27+ | 3/3 (100%) | Not measured |
Sacroiliitis | 8 (73%) | None |
 Clinical | 1 (12%) | |
 Imaging | 7 (88%) |